Diagnostic and Biotech

2016 Tumor Markers: Unlocking the Mystery of the Genetic Basis of Cancer-Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

  • VPG347299
  • 1200 Pages
  • October 2015
  • Diagnostic and Biotech

Complete report
$24,500. DataPack (test volumes, sales forecasts, supplier shares)
$15,900.

Highlights

- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years
- Examines trends in the U.S., Europe and Japan
- Reviews current and emerging tumor markers
- Analyzes applications of emerging diagnostic technologies
- Forecasts sales of major tumor markers by country and market segment
- Profiles leading market players and potential entrants
- Suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual tumor marker
and country.

- Ten-year test volume and sales forecasts for major
tumor markers by country and market segment,
including:

- Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Cancer Clinics
- Ambulatory Care Centers

- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
by country.

- Cancer statistics, etiology and recent developments in the
U.S., Japan and five major European countries.

Current and Emerging Products

- Review of over 200 current and emerging tumor markers,
including:

- Biochemical Markers
- Oncogenes
- Growth Factors
- Hormones
- Colony Stimulating Factors
- Lymphokines
- Immunohistochemical Stains, and others.

- Analysis of major immunoassay analyzers used for
tumor marker testing, including their operating characteristics,
features and selling prices.

Technology Review

- Assessment of monoclonal antibodies, immunoassays, DNA
probes, biochips/microarrays, chromosome analysis, IT,
artificial intelligence, flow cytometry, biosensors, and their
potential applications for tumor marker testing.

- Review of competing/complementing technologies, including
CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and
research centers developing new tumor markers and detection technologies.

Competitive Assessments

- Extensive strategic assessments of major suppliers
and start-up firms developing innovative
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Worldwide Market Overview

- Estimated universe of laboratories performing tumor marker testing
by country.

- Ten-year test volume and sales projections by country.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially
significant market appeal during the next ten years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on interviews with clinical pathologists, laboratory directors,
executives from leading diagnostic companies and start-up firms
developing innovative products, university scientists, as well as
experts from industry associations, venture capital firms and the
investment banking community in the U.S., five major European
countries and Japan.

The market projections are also based on questionnaire
responses received from hospitals, commercial/private laboratories,
physician offices/group practices, cancer clinics and ambulatory
care centers in seven countries.

In addition to primary sources of information, a comprehensive
review of the most recent technical and business publications, manufacturer
product literature, patents, trade association surveys, government
studies, marketing and technical meeting presentations,
industry analyst reports, and VPGMarketResearch's proprietary data files was conducted.

Contains 1,200 pages and 450 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Enteric Disease Testing Market (Therapeutics, Technologies and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Enteric disease is a condition caused in the intestine due to the presence of foreign antigen such as bacterial, viral and parasites. The enteric diseases are commonly caused due to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Label Free Detection Market (Technology, Product, Application, End User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast 2013 - 2020

The label free detection method is used for detecting biomolecules and their interactions. This method has emerged as an attractive research and development tool in the pharmaceutical and biotech industry. Partnerships between pharmaceutical companies and academic institutes and the rising number of drug discovery programs will boost market growth.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

European Microscopy Market - Opportunities and Forecasts, 2015 - 2020

Microscopy is a field of science in which objects are not visible to bare eye can be viewed under microscope. It is used to observe macromolecules and macromolecular complexes at ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

Global Biopharmaceuticals Market (Therapeutics, Products) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Biopharmaceuticals are drugs produced from genetically modified source, which are mainly proteins and nucleic acids. According to IMS Health Market Prognosis, the total market size of pharmaceutical industry was approximately ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Renal Biomarkers Market (Marker Type, Assay Platform, Application and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

North America Clinical Chemistry Analyzer Market - Opportunities and Forecast, 2015 - 2020

A clinical chemistry analyzer is use to analyze blood serum, plasma, urine and other body fluids with the help of various measurement technologies such as photometric and colorimetric testing, ion-selective ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

2017 © Copyright Big Market Research

View Pricing >>